La cadena de opciones muestra datos clave de las opciones de acciones de Renovaro a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Renovaro..

Renovaro (NASDAQ:RENB) Bolsa, Cadena de Opciones

Renovaro Biosciences

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Outlook
Due to ongoing tariff headwinds, economic activity remains subdued; no restocking has been observed as customers maintain a "wait and see" approach. This has created some headwinds to demand that were not anticipated at the beginning of the year, concentrated in the United States, where flat product apparent steel consumption (ASC) is now forecast to decline slightly in 2025 within the range of -2.0% to 0% (as compared to growth of 1.0% to 3.0% forecast at the beginning of the year). Section 232 tariffs have also increased costs and negatively impacted the supply/demand balance in Canada and Mexico markets.
In Europe demand is faring relatively better, and flat product ASC growth is expected in the range of -0.5% to +1.5% in 2025, only marginally below the forecast at the beginning of the year (+0% to +2.0%) due to more limited direct tariff impacts and support from lower interest rates. Looking beyond the near-term challenges (seasonal demand weakness and manufacturing activity at stable but low levels), inventories in Europe remain low, and the prospects of incremental trade policy support, a strengthened carbon border adjustment mechanism, together with higher infrastructure and defense spending, may materially improve the medium-term outlook.
So far this year, steel demand in Brazil has been stronger than initial expectations, and the Company now forecasts positive ASC growth of up to 2.0% in 2025 (vs. a stable demand forecast previously). India continues to be the fastest growing major steel market, with demand well supported particularly by infrastructure investment; ASC remains on track to increase in the range of 6.0% to 7.0% in 2025.
As a result, World ex-China ASC is now expected to grow by +1.5% to +2.5% in 2025, as compared to the initial +2.5% to +3.5% guidance provided at the beginning of the year. China's steel industry capacity remains unsustainable, and its elevated exports continue to weigh on ex-China fundamentals. China demand is expected to remain broadly stable in 2025, with the tariff impacts on exports and real estate weakness being offset by manufacturing and infrastructure demand.
Further contributions from strategic growth projects and Calvert consolidation should support 2H 2025 profitability which will face increased headwinds from Section 232 tariffs and impacts of seasonality. Free cash flow is expected to be positive in 2025, supported by a release of working capital in 2H 2025.
Looking to the medium term, the Company remains positive on the steel demand outlook and believes that it is optimally positioned to execute its strategy of growth with capital returns, and therefore has made no changes to its investment or capital return plans. Capex for 2025 remains guided at $4.5–$5.0 billion, including $1.4–$1.5 billion for strategic growth and $0.3–$0.4 billion for decarbonization projects. Furthermore, the completion and ramp-up of the Company's strategic growth projects is expected to support structurally higher EBITDA and investable cash flow in the coming periods.

News

Guidance

ArcelorMittal Holds $4.5B–$5.0B Capex For 2025; World ex-China Steel Demand Slows To +1.5%–2.5%; US ASC To Decline 0%–2%, India To Grow 6%–7%; H2 Profitability Seen Rising On Project Ramp-Up Despite Section 232 Tariff Pressures

Earnings

AB InBev Volumes Declined By 1.9% In Q2, With Beer Volumes Down By 2.2% And Non-Beer Volumes Up By 0.3%.

2025 Outlook
(i) Overall Performance: We expect our EBITDA to grow in line with our medium-term outlook of between 4-8%. The outlook for FY25 reflects our current assessment of inflation and other macroeconomic conditions.
(ii) Net Finance Costs: Net pension interest expenses and accretion expenses are expected to be in the range of 190 to 220 million USD per quarter, depending on currency and interest rate fluctuations. We expect the average gross debt coupon in FY25 to be approximately 4%.
(iii) Effective Tax Rate (ETR): We expect the normalized ETR in FY25 to be in the range of 26% to 28%. The ETR outlook does not consider the impact of potential future changes in legislation.
(iv) Net Capital Expenditure: We expect net capital expenditure of between 3.5 and 4.0 billion USD in FY25.

AB InBev Sees FY25 EBITDA Growing 4%–8% Amid Inflation, Macro Headwinds, Targets $3.5B–$4B Net Capital Expenditure; Says Finance Costs To Hit $190M–$220M Per Quarter In FY25, Tax Rate Seen At 26%–28%

Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) CEO Satya Nadella has said that working with leading AI startups like OpenAI helps sharpen the company's cloud infrastructure and product development, drawing a parallel to a time when he wished Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) had chosen Azure over Amazon.com, Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Amazon Web Services.
<h2 class="wp-block-heading">Nadella Wanted Netflix On Azure, Not AWS</h2>
During Microsoft's fiscal <a href="https://www.benzinga.com/markets/earnings/25/07/46738585/microsoft-q4-earnings-highlights-double-beat-ceo-says-cloud-and-ai-is-the-driving-force">fourth-quarter earnings</a> call on Wednesday, Morgan Stanley analyst Keith Weiss asked Nadella how the company manages the balance between supporting fast-growing AI startups — which are both major customers and potential competitors — and ensuring long-term value for Microsoft's cloud business.
In response, Nadella said Microsoft has been in similar positions before, referencing early cloud adoption in the streaming era.
"Back in the day when I was getting started on Azure, I used to look over the lake and sort of see Netflix and Amazon, and I say, ‘I wish Netflix ran on Azure,'" Nadella said. "And in some sense, that's kind of what we now have… the largest AI workloads run on Azure."
See Also: <a href="https://www.benzinga.com/markets/tech/25/07/46686037/nvidia-is-now-worth-twice-tesla-amd-palantir-and-intel-combined" target="_blank" rel="noreferrer noopener">Nvidia Is Now Worth Twice Tesla, AMD, Palantir, And Intel Combined</a>
<h2 class="wp-block-heading">AI Startups Like OpenAI Help Microsoft Optimize Its Cloud Stack</h2>
He explained that these high-demand AI applications, like ChatGPT and Copilot, allow Microsoft to optimize its entire data and software stack — including tools like Cosmos DB — around the needs of cutting-edge workloads.
"These are workload results that are invaluable for us to learn to build both the products as well as the platform," he said.
<h2 class="wp-block-heading">Microsoft Eyes Broad Adoption Beyond Leading AI Players</h2>
Nadella underscored that Microsoft's strategy includes not just supporting headline AI startups but also tracking usage across a "broad diffusion" of second-tier AI apps, ensuring scalability and relevance for a wide customer base.
<h2 class="wp-block-heading">Azure Posts Strong Growth, Hits $75 Billion In Annual Revenue</h2>
Microsoft reported fourth-quarter revenue of $76.44 billion, marking a 17% year-over-year increase and surpassing the Street estimate of $73.80 billion.
The Intelligent Cloud segment brought in $29.9 billion, up 26% from a year ago. Azure and other cloud services within the Intelligent Cloud segment posted a 39% year-over-year revenue increase.
Nadella noted that Azure crossed $75 billion in <a href="https://www.benzinga.com/etfs/sector-etfs/25/07/46735066/microsofts-74-billion-ai-surprise-etfs-bet-big-on-azures-secret-weapon">revenue for the full fiscal</a> year, up 34% year-over-year.
<h2 class="wp-block-heading">Microsoft Still Trails AWS In Global Cloud Market</h2>
As of the fourth quarter 2024, AWS maintains its lead in the global cloud infrastructure market with a 30% share, according to Synergy Research Group.
Microsoft Azure followed at 21%, and Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google Cloud held 12%. Together, the &#8220;Big Three&#8221; controlled over 60% of the market, while all other providers remained in the low single digits.
Price Action: On Wednesday, Microsoft shares edged up 0.13% during regular trading and jumped 8.28% in after-hours trading, according to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0717">Benzinga Pro</a>.
Benzinga&#8217;s Edge Stock Rankings show that MSFT maintains strong momentum across short, medium and long-term periods, although its value rating remains relatively low. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Additional performance details are available here</a>.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/31010841/Screenshot-2025-07-31-at-10.27.48%E2%80%AFAM.png" alt="" class="wp-image-1008297" /></a></figure>
Photo Courtesy: Dragos Asaftei on Shutterstock.com
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46127671/amazon-loses-top-ai-leader-in-high-stakes-talent-shuffle" target="_blank" rel="noreferrer noopener">Amazon Loses Top AI Leader In High-Stakes Talent Shuffle</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

AMZN

GOOG

GOOGL

MSFT

NFLX

Satya Nadella Says He Used To Gaze Over The Lake And Wish Netflix Would Use Azure, But Is Happy The Tide Has Turned With OpenAI

Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) raises FY2025 sales outlook from $325.000 million-$340.000 million to $335.000 million-$350.000 million vs $327.467 million estimate.

PHAR

Pharming Raises FY2025 Sales Guidance from $325.000M-$340.000M to $335.000M-$350.000M vs $327.467M Est

argenx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) reported quarterly earnings of $3.74 per share which beat the analyst consensus estimate of $2.77 by 34.87 percent. This is a 731.11 percent increase over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $967.19 million which beat the analyst consensus estimate of $868.16 million by 11.41 percent. This is a 97.62 percent increase over sales of $489.43 million the same period last year.

Earnings Beats

ARGX

argenx Q2 EPS $3.74 Beats $2.77 Estimate, Sales $967.19M Beat $868.16M Estimate

Analysts and experts are reacting to the Federal Reserve keeping its benchmark interest rate unchanged at 4.25% to 4.50% on Wednesday&#8217;s Federal Open Market Committee Meeting, amid mounting pressure from President Donald Trump to deliver immediate and aggressive rate cuts.
What Happened: Economist Mohamed El-Erian noted that yet again, &#8220;it is the post-FOMC press conference that moves the markets,&#8221; rather than the outcome of the meeting itself. 
El-Erian, who is currently the Chief Economic Adviser at Allianz, highlighted the fact that &#8220;stocks fall, bond yields rise, and the dollar strengthens,&#8221; as a result of the Fed&#8217;s remarks, while adding that Fed Chair Jerome Powell &#8220;sounds more hawkish than many expected on the outlook for policy rates.&#8221;
See Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46735480/bitcoin-ethereum-xrp-dogecoin-decline-after-federal-reserve-holds-rates">Bitcoin, Ethereum, XRP, Dogecoin Decline After Federal Reserve Holds Rates</a>
Here, El-Erian is referring to the Fed&#8217;s readiness to keep rates elevated if needed, not giving any hints of possible rate cuts in the next meeting.
<figure class="wp-block-embed aligncenter is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Once again, it is the post-FOMC press conference that moves the markets: Stocks fall, bond yields rise, and the dollar strengthens as Chair Powell sounds more hawkish than many expected on the outlook for policy rates.<a href="https://twitter.com/hashtag/economy?src=hash&amp;ref_src=twsrc%5Etfw">#economy</a> <a href="https://twitter.com/hashtag/markets?src=hash&amp;ref_src=twsrc%5Etfw">#markets</a> <a href="https://twitter.com/hashtag/FederalReserve?src=hash&amp;ref_src=twsrc%5Etfw">#FederalReserve</a> <a href="https://t.co/s1lt3KuFRL">pic.twitter.com/s1lt3KuFRL</a>
&mdash; Mohamed A. El-Erian (@elerianm) <a href="https://twitter.com/elerianm/status/1950636773610287329?ref_src=twsrc%5Etfw">July 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Former Boston Fed President Eric Rosengren warned that this meeting was unlikely to offer clear forward guidance. He pointed out that the labor market remains tight, saying &#8220;unemployment still at full employment,&#8221; and inflation continues to hover above the Fed's 2% target.
In his view, policymakers are likely to maintain a cautious, &#8220;data dependent&#8221; approach rather than committing to a definitive path.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Expect little clarity from this fomc meeting. Unemployment still at full employment, inflation has leveled off well above target. Expect to continue to be &quot;data dependent&quot; with the possibility of two dissents being of little signaling value to the future path of the ff rate
&mdash; Eric Rosengren (@EricSRosengren) <a href="https://twitter.com/EricSRosengren/status/1950535580409795036?ref_src=twsrc%5Etfw">July 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Goldman Sachs&#8217; Ashish Shah, notes the &#8216;historic&#8217; dissent vote, referring to the fact that the Central Bank&#8217;s decision was not unanimous, but was reached by a 9-2 vote. 
&#8220;It's the first time we've seen two board members dissent since 1993,&#8221; he says, adding that &#8220;As expected Governors Bowman and Waller were dovish outliers, with the majority of the FOMC instead preferring to wait to learn more about the inflation process over the summer,&#8221; as quoted by Bloomberg finance correspondent, Sonali Basak.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Goldman&#39;s Ashish Shah: &quot;As expected Governors Bowman and Waller were dovish outliers, with the majority of the FOMC instead preferring to wait to learn more about the inflation process over the summer.&quot; It&#39;s the first time we&#39;ve seen two board members dissent since 1993. Market…
&mdash; Sonali Basak (@sonalibasak) <a href="https://twitter.com/sonalibasak/status/1950625003520868660?ref_src=twsrc%5Etfw">July 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Powell had told Congress over a month ago that the Fed&#8217;s <a href="https://www.benzinga.com/markets/economic-data/25/06/46077396/powell-interest-rates-trump-inflation-tariffs">near-term policy uncertainty</a> revolves entirely around Trump&#8217;s tariffs. &#8220;Increases in tariffs this year are likely to push up prices and weigh on economic activity,&#8221; Powell said during the hearing.
Despite his verbal jabs at the Fed Chair, Trump said last week that he <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46621837/trump-says-not-necessary-to-fire-jerome-powell-but-presses-fed-chair-on-rate-cuts-and-2-5-billion-renovation-id-love-him-to-lower-interest-rates">does not intend</a> to fire Powell, saying that, &#8220;To do so is a big move and I just don't think it's necessary.&#8221;
He did, however, continue to press for lower interest rates, saying that &#8220;I'd love him to lower interest rates,&#8221; during a visit to the Fed&#8217;s headquarters last week. 
Photo Courtesy: Poetra.RH on Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46733603/fed-holds-trump-powell-waller-bowman-interest-rates">Fed Skips Rate Cut Again—But Reveals Something We Haven&#8217;t Seen Since 1993</a></li>
</ul>

Equities

Government

Bonds

Federal Reserve

Markets

Fed Holds Rates Amid Trump's Demands For A Cut: Powell 'More Hawkish Than Anyone Expected,' Say Economists — Historic' Dissent Noted

ING Groep (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ING#NYSE">ING</a>) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.53 by 19.54 percent. This is a 8.62 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $6.465 billion which beat the analyst consensus estimate of $5.649 billion by 14.45 percent. This is a 5.05 percent increase over sales of $6.154 billion the same period last year.

ING Groep Q2 EPS US$0.63 Beats US$0.53 Estimate, Sales US$6.465B Beat US$5.649B Estimate.

Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.03) by 340 percent. This is a 400 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $93.20 million which beat the analyst consensus estimate of $82.63 million by 12.79 percent. This is a 25.78 percent increase over sales of $74.10 million the same period last year.

Pharming Q2 EPS $0.06 Beats $(0.03) Estimate, Sales $93.20M Beat $82.63M Estimate

Impinj Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) witnessed a 22.67% surge in its stock price after-hours, after the company released its second-quarter financial results.
Check out how <a href="https://www.benzinga.com/quote/PI">PI stock is trading here</a>.
What Happened: The stock of the Seattle-based company specializing in connecting everyday objects to the internet closed at $122.21, marking a 0.49% decline on Wednesday. According to the <a href="https://www.benzinga.com/quote/PI">Benzinga pro</a> data, the stock surged 22.67% to $149.92, gaining $27.71 during after-hours trading.
The surge followed the release of Impinj&#8217;s second-quarter financial results.
See Also: <a href="https://benzinga.com/markets/macro-economic-events/25/07/46744534/trump-pleased-with-450b-south-korea-tariff-deal-seoul-to-accept-us-cars-agriculture-economist-warns-americans-pay-the-15-tariff">Trump &#8216;Pleased&#8217; With $450B South Korea Tariff Deal, Seoul To Accept US Cars, Agriculture: Economist Warns Americans &#8216;Pay&#8217; The 15% Tariff</a>
Chris Diorio, co-founder and CEO of Impinj stated, "Our second-quarter results were strong, with revenue and adjusted EBITDA exceeding our guidance.
Why It Matters: Impinj&#8217;s strong financial results have been a key factor in the stock&#8217;s performance. The company&#8217;s second-quarter revenue was $97.9 million. The Generally Accepted Accounting Principles net income was $11.6 million, or $0.39 per diluted share using 29.7 million shares. The adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization was $27.6 million, and the non-GAAP net income was $24.5 million, or income of $0.80 per diluted share using 32.2 million shares.
Impinj also provided a financial outlook for the third quarter of 2025, with a revenue forecast of $91.0 to $94.0 million and a GAAP net loss of ($2.2) to ($0.7) million.&nbsp;
Benzinga's Edge Stock Rankings indicate that PI stock is showing an uptick in both the short- and medium-term. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-3/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Know</a> the stock value of other players.&nbsp;
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/PI"><img loading="lazy" decoding="async" width="457" height="106" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/31004349/Screenshot-2025-07-31-101333.png" alt="" class="wp-image-1008288" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/31004349/Screenshot-2025-07-31-101333.png 457w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/31004349/Screenshot-2025-07-31-101333-300x70.png 300w" sizes="(max-width: 457px) 100vw, 457px" /></a></figure>
<ul class="wp-block-list">
<li>Read Next: <a href="https://benzinga.com/markets/cryptocurrency/22/05/26996975/the-skycoin-story-how-listing-and-delisting-work-in-the-crypto-world">The Skycoin Story: How Listing And Delisting Work In The Crypto World</a></li>
</ul>
Photo Courtesy: Kanyapak Lim on Shutterstock.com
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Impinj Soars 23% After Hours On 'Strong' Q2 Report

ArcelorMittal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MT#NYSE">MT</a>) reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.07 by 22.79 percent. This is a 109.52 percent increase over earnings of $0.63 per share from the same period last year. The company reported quarterly sales of $15.93 billion which beat the analyst consensus estimate of $15.56 billion by 2.35 percent. This is a 1.99 percent decrease over sales of $16.25 billion the same period last year.

ArcelorMittal Q2 Adj. EPS $1.32 Beats $1.07 Estimate, Sales $15.93B Beat $15.56B Estimate

Anheuser-Busch InBev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>) reported quarterly earnings of $1.06 per share which beat the analyst consensus estimate of $0.97 by 9.28 percent. This is a 17.78 percent increase over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $15.00 billion which missed the analyst consensus estimate of $15.38 billion by 2.45 percent. This is a 2.15 percent decrease over sales of $15.33 billion the same period last year.

Earnings Misses

Anheuser-Busch InBev Q2 Adj. EPS $1.06 Beats $0.97 Estimate, Sales $15.00B Miss $15.38B Estimate

Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) shared its second-quarter 2025 financial results, posting a record $50.2 billion in revenue, as well as the impacts of President Donald Trump's tariffs during the company's earnings call with investors.
Check out the latest price of <a href="https://www.benzinga.com/quote/F">F stock here</a>.
What Happened: "We expect tariffs to be a net headwind of about $2 billion this year," Ford CEO Jim Farley said during the earnings call with investors on Wednesday, adding that the company was closely working with policymakers and monitoring developments.
"We want to simplify the tariffs so that we can make up for that gap between the bilateral import tariff rates and what we&#8217;re paying in our tariff bill," Farley said in a Q&amp;A session with investors during the earnings call.&nbsp;
He also added that Ford is "in daily contact" with the lawmakers over tariffs and has the opportunity to reduce tariff liability given its strong domestic manufacturing capabilities.
Farley also shared that the new emission norms have reduced the pressure on the company to buy ZEV credits and saved over $1.5 billion in costs. The relaxed norms also help Ford Blue, the company's ICE-powered vehicle line, explore "multi-billion dollar" opportunities over the next two years.&nbsp;
"We support a single durable national emission standard to ensure sound industry planning," Farley said, adding that the EPA's announcement helps Ford with "greater powertrain optionality."
Ford Model E, the company's electric vehicle lineup, also experienced growth, with revenues reaching $2.4 billion, but it also reported an EBIT loss of $1.3 billion, $179 million higher than the previous year.
"We have scheduled an event on Aug. 11 in Kentucky where we will share more about our plans to design and build breakthrough electric vehicles in America," the company said.
Why It Matters: The news comes as Ford shared its <a href="https://www.benzinga.com/markets/earnings/25/07/46740005/ford-q2-earnings-revenue-eps-beat-estimates-shares-slide-as-automaker-warns-of-2-billion-tariff-headwind">Q2 earnings recently</a>, posting a strong performance for the company in the U.S. despite uncertainty in the auto industry.
The company has also pushed for <a href="https://www.benzinga.com/markets/tech/25/07/46436042/ford-responds-to-trumps-ev-policy-shift-with-push-for-affordable-electric-models">more affordable EVs</a> in the U.S. despite Trump's <a href="https://www.benzinga.com/markets/tech/25/07/46289556/trumps-tax-bill-axes-the-7500-ev-credit-heres-how-you-can-still-claim-it">anti-EV stance</a>, with the company planning to introduce more EVs and electrified vehicles in its lineup.
Elsewhere, the EPA, or Environmental Protection Agency, announced a proposal to rescind the crucial <a href="https://www.benzinga.com/news/politics/25/07/46714902/trump-epa-wants-to-overturn-2009-endangerment-finding-that-controls-carbon-emissions-to-end-16-years-of-uncertainty-for-automakers">2009 Endangerment Finding</a>, which forms the basis for much of the U.S.'s climate action. Rolling it back would free automakers from any legal pressure to reduce carbon emissions.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="204" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/31000837/F-JUL-31-2025-1024x204.jpg" alt="" class="wp-image-1008244" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/31000837/F-JUL-31-2025-1024x204.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/31000837/F-JUL-31-2025-300x60.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/31000837/F-JUL-31-2025-768x153.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/31000837/F-JUL-31-2025-1536x307.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/31000837/F-JUL-31-2025.jpg 1563w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Ford scores well on the Growth, Quality and Value metrics and offers satisfactory Momentum. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge Stock Rankings</a> today!
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/personal-finance/management/25/07/46695993/ford-ceo-found-young-people-didnt-want-to-work-there-because-17-wages-left-them-so-stressed-then-he-made-an-expensive-change-the-country-needs">Ford CEO Found Young People Didn&#8217;t Want to Work There Because $17 Wages Left Them &#8216;So Stressed&#8217; &#8211; Then He Made An Expensive Change &#8216;The Country Needs&#8217;</a></li>
</ul>
Photo courtesy: Tada Images / Shutterstock.com

Tech

Ford CEO Warns Of $2 Billion Hit From Trump Tariffs In 2025 Despite Q2 Earnings Surge, Says Levies Need To Be Simplified

Macro Economic Events

Econ #s

Economics

Reported Earlier, China Non-Manufacturing Purchasing Managers Index For July 50.1 Vs. 50.3 Est.; 50.5 Prior

Reported Earlier, China Manufacturing Purchasing Managers Index For July 49.3 Vs. 49.7 Est.; 49.7 Prior

Reported Earlier, China Composite Purchasing Managers' Index For July 50.2 Vs. 50.7 Prior

Reported Earlier, Australia Retail Sales (MoM) For June 1.2% Vs. 0.4% Est.; 0.1% (Revised) Prior

Reported Earlier, Australia Building Approvals (MoM) Preliminary For June 11.9% Vs. 1.8% Est.; 2.2% (Revised) Prior

BBJP

WisdomTree Trust Japan Total Dividend Fund

Reported Earlier, Japan Industrial Production (MoM) Preliminary For June 1.7% Vs. -0.7% Est.; -0.1% Prior

Reported Earlier, Japan Interest Rate Decision Unchanged At 0.50%

Legal

Press Releases

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Small Cap

Opinion

AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

Smart Healthcare Is Taking Over. Here's Where the Money's Headed

Biotech

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks

AVAI

CCLD

CCLDO

CERT

GEHC

HCTI

MDAI

OMDA

POAI

RENB

TREN

Adicet Bio

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

Avalo Therapeutics

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

CervoMed

Cue Biopharma

Fortress Biotech

Gain Therapeutics

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

ImmuCell

MiNK Therapeutics

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Opus Genetics

MediciNova

OS Therapies

PMV Pharma

Pyxis Oncology

Renovaro

Repare Therapeutics

Serina Therapeutics

Sutro Biopharma

Unicycive Therapeutics, Inc. - Common Stock

Unicycive Therapeutics

Screenshot 2024-05-06 at 6.05.33 PM

General

NVDA

Renovaro Inc. (NASDAQ: RENB) Aims To Revolutionize Cancer Detection And Treatment Using Multi-Cancer Detection Model With Nvidia AI Chips For Leadership In Early Detection

Comments

Renovaro

Renovaro (RENB) Opciones

Renovaro (NASDAQ:RENB) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL